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We live in both exciting and challenging 
times in the world of diabetes. This is particularly 
true in relation to the development of new 
therapies; systems for delivery of care; and 
strategies focused on patient empowerment, 
with the ultimate goal of targeting patient-
specific endpoints.
There are multiple new therapies and possible 
therapeutic targets that have the potential 
to revolutionize the clinical approach to the 
management of diabetes. At any given moment, 
there are considerable data and debates relating 
to the mechanism of action, efficacy, safety, and 
cost-effectiveness of such therapies.
Similarly, controversy and debate persists 
regarding the development and implementation 
of optimal treatment strategies, particularly 
in the context of ever-changing guidelines 
and advancing technologies. It is therefore 
a considerable challenge for medical and 
paramedical staff involved in the care of people 
with diabetes to keep up to date and make 
informed decisions regarding the multitude of 
issues facing the diabetes care community.
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With the plethora of information and 
information sources, there is a clear need for a 
resource that addresses the multitude of issues 
facing the practicing clinician.
This novel journal is a unique open access 
resource that brings together experts in their 
fields to clearly address and provide up-to-
date information and evidence relating to the 
numerous scientific issues and clinical challenges 
in the ever changing arena of diabetes care.
The online open access nature of this journal 
provides an invaluable opportunity for all 
healthcare professionals to freely access novel, 
high-quality, cutting-edge data and opinion on 
the numerous issues involved in 21st-century 
diabetes care.
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